Hologic, Inc. (HOLX) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hologic (HOLX) PT, Estimates Raised at Jefferies Post Q2
May 1, 2014 9:46 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Hologic (NASDAQ: HOLX) to $26.00 (from $24.00) following solid Q2 results.
Denhoy commented, "HOLX put up a F2Q beat on strength in Tomo and... More
Hologic (HOLX) Buy Reiterated a Needham & Company Post Q2 on 'Encouraging' Return to Rev Growth
May 1, 2014 7:15 AM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and $26 price target on Hologic (NASDAQ: HOLX) following Q2 results which showed an 'encouraging' return to positive revenue growth.
Matson comments, "HOLX's F2Q14 results were well above consensus. Revenue upside was driven... More
